PDL BioPharma, Inc.
September 8, 2017
PDL BioPharma, Inc., an Incline Village company that manages a portfolio of companies, products, royalty agreements and debt facilities in the biotech, pharmaceutical and medical device industries, announced that John P. McLaughlin, PDL's president and chief executive officer, will present at two investor conferences in September.
McLaughlin will attend the Rodman & Renshaw 19th Annual Global Investment Conference Monday, Sept. 11, and the 2017 Cantor Fitzgerald Global Healthcare Conference Monday, Sept. 25, both in New York City.
Trending In: News Briefs
- Crews begin revitalization work at Tahoe’s Cal Neva property
- Carson City Holiday Inn sold for $12.5 million
- Reno airport adds 10th airline; new nonstop routes to Portland offered
- Business of using ketamine to treat depression, PTSD, other ailments is growing
- NV colleges seek $1.5 billion; state employee pay raise part of reason